{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T22:07:53Z","timestamp":1750284473009,"version":"3.37.3"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,1,25]],"date-time":"2024-01-25T00:00:00Z","timestamp":1706140800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,1,25]],"date-time":"2024-01-25T00:00:00Z","timestamp":1706140800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["401837\/2016-5","303072\/2019-9"],"award-info":[{"award-number":["401837\/2016-5","303072\/2019-9"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","award":["PNPD fellowship"],"award-info":[{"award-number":["PNPD fellowship"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1007\/s00213-024-06533-9","type":"journal-article","created":{"date-parts":[[2024,1,25]],"date-time":"2024-01-25T08:02:19Z","timestamp":1706169739000},"page":"1001-1010","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Activation of NOP receptor increases vulnerability to stress: role of glucocorticoids and CRF signaling"],"prefix":"10.1007","volume":"241","author":[{"given":"Victor A. D.","family":"Holanda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raissa N.","family":"de Almeida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matheus C","family":"de Oliveira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edilson D.","family":"da Silva Junior","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole L.","family":"Galv\u00e3o-Coelho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Girolamo","family":"Calo\u2019","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiara","family":"Ruzza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8967-1369","authenticated-orcid":false,"given":"Elaine C.","family":"Gavioli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,1,25]]},"reference":[{"key":"6533_CR1","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.neuropharm.2016.02.003","volume":"105","author":"L Asth","year":"2016","unstructured":"Asth L, Ruzza C, Malfacini D, Medeiros I, Guerrini R, Zaveri NT, Gavioli EC, Calo\u2019 G (2016) Beta-arrestin 2 rather than G protein efficacy determines the anxiolytic-versus antidepressant-like effects of nociceptin\/orphanin FQ receptor ligands. Neuropharmacology 105:434\u2013442. https:\/\/doi.org\/10.1016\/j.neuropharm.2016.02.003","journal-title":"Neuropharmacology"},{"key":"6533_CR2","doi-asserted-by":"publisher","first-page":"657153","DOI":"10.3389\/fnins.2021.657153","volume":"15","author":"J Azevedo Neto","year":"2021","unstructured":"Azevedo Neto J, Ruzza C, Sturaro C, Malfacini D, Pacifico S, Zaveri NT, Calo\u2019 G (2021) Functional selectivity does not predict antinociceptive\/locomotor impairing potencies of NOP receptor agonists. Front Neurosci 15:657153. https:\/\/doi.org\/10.3389\/fnins.2021.657153","journal-title":"Front Neurosci"},{"key":"6533_CR3","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/0091-3057(94)90093-0","volume":"49","author":"M B\u00e1ez","year":"1994","unstructured":"B\u00e1ez M, Volosin M (1994) Corticosterone influences forced-swim induced immobility. Pharmacol Biochem Behav 49:729\u2013736","journal-title":"Pharmacol Biochem Behav"},{"issue":"6","key":"6533_CR4","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1111\/j.1365-2982.2005.00717.x","volume":"17","author":"M Broccardo","year":"2005","unstructured":"Broccardo M, Scaccianoce S, Del Bianco P, Agostini S, Petrella C, Improta G (2005) Nociceptin\/orphanin FQ-induced delay in gastric emptying: role of central corticotropin-releasing factor and glucocorticoid receptors. Neurogastroenterol Motil 17(6):871\u2013877. https:\/\/doi.org\/10.1111\/j.1365-2982.2005.00717.x","journal-title":"Neurogastroenterol Motil"},{"issue":"2","key":"6533_CR5","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1159\/000124900","volume":"47","author":"ER De Kloet","year":"1988","unstructured":"De Kloet ER, De Kock S, Schild V, Veldhuis HD (1988) Antiglucocorticoid RU 38486 attenuates retention of a behaviour and disinhibits the hypothalamic-pituitary adrenal axis at different brain sites. Neuroendocrinology 47(2):109\u2013115. https:\/\/doi.org\/10.1159\/000124900","journal-title":"Neuroendocrinology"},{"issue":"6","key":"6533_CR6","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/nrn1683","volume":"6","author":"ER De Kloet","year":"2005","unstructured":"De Kloet ER, Jo\u00ebls M, Holsboer F (2005) Stress and the brain: from adaptation to disease. Nat Rev Neurosci 6(6):463\u2013475. https:\/\/doi.org\/10.1038\/nrn1683","journal-title":"Nat Rev Neurosci"},{"issue":"12","key":"6533_CR7","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1111\/j.1365-2826.2012.02361.x","volume":"24","author":"G Delaney","year":"2012","unstructured":"Delaney G, Dawe KL, Hogan R, Hunjan T, Roper J, Hazell G, Lolait SJ, Fulford AJ (2012) Role of nociceptin\/orphanin FQ and NOP receptors in the response to acute and repeated restraint stress in rats. J Neuroendocrinol 24(12):1527\u20131541. https:\/\/doi.org\/10.1111\/j.1365-2826.2012.02361.x","journal-title":"J Neuroendocrinol"},{"issue":"9-10","key":"6533_CR8","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1007\/s00213-017-4584-y","volume":"234","author":"A Der-Avakian","year":"2017","unstructured":"Der-Avakian A, D\u2019Souza MS, Potter DN, Chartoff EH, Carlezon WA Jr, Pizzagalli DA, Markou A (2017) Social defeat disrupts reward learning and potentiates striatal nociceptin\/orphanin FQ mRNA in rats. Psychopharmacology (Berl) 234(9-10):1603\u20131614. https:\/\/doi.org\/10.1007\/s00213-017-4584-y","journal-title":"Psychopharmacology (Berl)"},{"issue":"3","key":"6533_CR9","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/s0306-4522(00)00517-0","volume":"102","author":"DP Devine","year":"2001","unstructured":"Devine DP, Watson SJ, Akil H (2001) Nociceptin\/orphanin FQ regulates neuroendocrine function of the limbic-hypothalamic-pituitary-adrenal axis. Neuroscience 102(3):541\u2013553. https:\/\/doi.org\/10.1016\/s0306-4522(00)00517-0","journal-title":"Neuroscience"},{"key":"6533_CR10","doi-asserted-by":"publisher","first-page":"109077","DOI":"10.1016\/j.neuropharm.2022.109077","volume":"212","author":"F D\u2019Oliveira da Silva","year":"2022","unstructured":"D\u2019Oliveira da Silva F, Azevedo Neto J, Sturaro C, Guarino A, Robert C, Gavioli EC, Calo G, Mouledous L, Ruzza C (2022) The NOP antagonist BTRX-246040 increases stress resilience in mice without affecting adult neurogenesis in the hippocampus. Neuropharmacology 212:109077. https:\/\/doi.org\/10.1016\/j.neuropharm.2022.109077","journal-title":"Neuropharmacology"},{"issue":"1","key":"6533_CR11","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/sj.npp.1300308","volume":"29","author":"F Fernandez","year":"2004","unstructured":"Fernandez F, Misilmeri MA, Felger JC, Devine DP (2004) Nociceptin\/orphanin FQ increases anxiety-related behavior and circulating levels of corticosterone during neophobic tests of anxiety. Neuropsychopharmacology 29(1):59\u201371. https:\/\/doi.org\/10.1038\/sj.npp.1300308","journal-title":"Neuropsychopharmacology"},{"doi-asserted-by":"publisher","unstructured":"Ferrari F, Rizzo S, Ruzza C, Calo\u2019 G (2020) Detailed in vitro pharmacological characterization of the clinically viable nociceptin\/orphanin FQ peptide receptor antagonist BTRX-246040. J Pharmacol Exp Ther 373(1):34-43. https:\/\/doi.org\/10.1124\/jpet.119.262865","key":"6533_CR12","DOI":"10.1124\/jpet.119.262865"},{"issue":"10","key":"6533_CR13","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1016\/j.peptides.2007.08.003","volume":"28","author":"R Filippetti","year":"2007","unstructured":"Filippetti R, Kloting I, Massi M, Cifani C, Polidori C (2007) Involvement of cocaine-amphetamine regulated transcript in the differential feeding responses to nociceptin\/orphanin FQ in dark agouti and Wistar Ottawa Karlsburg W rats. Peptides 28(10):1966\u20131973. https:\/\/doi.org\/10.1016\/j.peptides.2007.08.003","journal-title":"Peptides"},{"issue":"6","key":"6533_CR14","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/j.biopsych.2019.09.013","volume":"87","author":"M Flanigan","year":"2020","unstructured":"Flanigan M, Tollefson S, Himes ML, Jordan R, Roach K, Stoughton C, Lopresti B, Mason NS, Ciccocioppo R, Narendran R (2020) Acute elevations in cortisol increase the in vivo binding of [11C]NOP-1A to nociceptin receptors: a novel imaging paradigm to study the interaction between stress- and antistress-regulating neuropeptides. Biol Psychiatry 87(6):570\u2013576. https:\/\/doi.org\/10.1016\/j.biopsych.2019.09.013","journal-title":"Biol Psychiatry"},{"key":"6533_CR15","doi-asserted-by":"publisher","first-page":"169","DOI":"10.3389\/fnins.2013.00169","volume":"7","author":"JH Fox","year":"2013","unstructured":"Fox JH, Lowry CA (2013) Corticotropin-releasing factor-related peptides, serotonergic systems, and emotional behavior. Fronti Neurosci 7:169. https:\/\/doi.org\/10.3389\/fnins.2013.00169","journal-title":"Fronti Neurosci"},{"doi-asserted-by":"publisher","unstructured":"Gavioli EC, Calo\u2019 G (2013) Nociceptin\/orphanin FQ receptor antagonists as innovative antidepressant drugs. Pharmacol Ther 140(1):10-25. https:\/\/doi.org\/10.1016\/j.pharmthera.2013.05.008","key":"6533_CR16","DOI":"10.1016\/j.pharmthera.2013.05.008"},{"key":"6533_CR17","doi-asserted-by":"publisher","first-page":"170548","DOI":"10.1016\/j.peptides.2021.170548","volume":"141","author":"EC Gavioli","year":"2021","unstructured":"Gavioli EC, Holanda VAD, Calo\u2019 G, Ruzza C (2021) Nociceptin\/orphanin FQ receptor system blockade as an innovative strategy for increasing resilience to stress. Peptides 141:170548. https:\/\/doi.org\/10.1016\/j.peptides.2021.170548","journal-title":"Peptides"},{"issue":"9","key":"6533_CR18","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.1046\/j.1460-9568.2003.02603.x","volume":"17","author":"EC Gavioli","year":"2003","unstructured":"Gavioli EC, Marzola G, Guerrini R, Bertorelli R, Zucchini S, De Lima TC, Rae GA, Salvadori S, Regoli D, Calo\u2019 G (2003) Blockade of nociceptin\/orphanin FQ-NOP receptor signalling produces antidepressant-like effects: pharmacological and genetic evidences from the mouse forced swimming test. Eur J Neurosci 17(9):1987\u20131990. https:\/\/doi.org\/10.1046\/j.1460-9568.2003.02603.x","journal-title":"Eur J Neurosci"},{"issue":"6","key":"6533_CR19","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1007\/s00210-004-0939-0","volume":"369","author":"EC Gavioli","year":"2004","unstructured":"Gavioli EC, Vaughan CW, Marzola G, Guerrini R, Mitchell VA, Zucchini S, De Lima TC, Rae GA, Salvadori S, Regoli D, Calo\u2019 G (2004) Antidepressant-like effects of the nociceptin\/orphanin FQ receptor antagonist UFP-101: new evidence from rats and mice. Naunyn Schmiedebergs Arch Pharmacol 369(6):547\u2013553. https:\/\/doi.org\/10.1007\/s00210-004-0939-0","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"S1","key":"6533_CR20","doi-asserted-by":"publisher","first-page":"S26","DOI":"10.1097\/01.psy.0000163456.22154.d2","volume":"67","author":"CF Gillespie","year":"2005","unstructured":"Gillespie CF, Nemeroff CB (2005) Hypercortisolemia and depression. Psychosom Med 67(S1):S26\u2013S28. https:\/\/doi.org\/10.1097\/01.psy.0000163456.22154.d2","journal-title":"Psychosom Med"},{"issue":"6","key":"6533_CR21","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.npep.2007.09.002","volume":"41","author":"MK Green","year":"2007","unstructured":"Green MK, Barbieri EV, Brown BD, Chen KW, Devine DP (2007) Roles of the bed nucleus of stria terminalis and of the amygdala in N\/OFQ-mediated anxiety and HPA axis activation. Neuropeptides 41(6):399\u2013410. https:\/\/doi.org\/10.1016\/j.npep.2007.09.002","journal-title":"Neuropeptides"},{"issue":"1","key":"6533_CR22","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1176\/ajp.153.1.93","volume":"153","author":"IJ Heuser","year":"1996","unstructured":"Heuser IJ, Schweiger U, Gotthardt U, Schmider J, Lammers CH, Dettling M, Yassouridis A, Holsboer F (1996) Pituitary-adrenal-system regulation and psychopathology during amitriptyline treatment in elderly depressed patients and normal comparison subjects. Am J Psychiatry 153(1):93\u201399. https:\/\/doi.org\/10.1176\/ajp.153.1.93","journal-title":"Am J Psychiatry"},{"issue":"13","key":"6533_CR23","doi-asserted-by":"publisher","first-page":"2525","DOI":"10.1007\/s00213-016-4310-1","volume":"233","author":"VA Holanda","year":"2016","unstructured":"Holanda VA, Medeiros IU, Asth L, Guerrini R, Calo\u2019 G, Gavioli EC (2016) Antidepressant activity of nociceptin\/orphanin FQ receptor antagonists in the mouse learned helplessness. Psychopharmacology (Berl) 233(13):2525\u20132532. https:\/\/doi.org\/10.1007\/s00213-016-4310-1","journal-title":"Psychopharmacology (Berl)"},{"key":"6533_CR24","doi-asserted-by":"publisher","first-page":"100255","DOI":"10.1016\/j.ynstr.2020.100255","volume":"13","author":"VAD Holanda","year":"2020","unstructured":"Holanda VAD, Oliveira MC, Da Silva Junior ED, Calo\u2019 G, Ruzza C, Gavioli EC (2020) Blockade of nociceptin\/orphanin FQ signaling facilitates an active copying strategy due to acute and repeated stressful stimuli in mice. Neurobiol Stress 13:100255. https:\/\/doi.org\/10.1016\/j.ynstr.2020.100255","journal-title":"Neurobiol Stress"},{"key":"6533_CR25","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.brainresbull.2021.11.005","volume":"178","author":"VAD Holanda","year":"2022","unstructured":"Holanda VAD, Oliveira MC, da Silva Junior ED, Gavioli EC (2022) Tamsulosin facilitates depressive-like behaviors in mice: involvement of endogenous glucocorticoids. Brain Res Bull 178:29\u201336. https:\/\/doi.org\/10.1016\/j.brainresbull.2021.11.005","journal-title":"Brain Res Bull"},{"doi-asserted-by":"publisher","unstructured":"Holanda VAD, Pacifico S, Azevedo Neto J, Finetti L, Lob\u00e3o-Soares B, Calo\u2019 GG, Gavioli EC, Ruzza C (2019) Modulation of the NOP receptor signaling affects resilience to acute stress. J Psychopharmacol 33(12):1540-1549. https:\/\/doi.org\/10.1177\/0269881119864942","key":"6533_CR26","DOI":"10.1177\/0269881119864942"},{"issue":"11","key":"6533_CR27","doi-asserted-by":"publisher","first-page":"3093","DOI":"10.1007\/s00213-018-5004-7","volume":"235","author":"VAD Holanda","year":"2018","unstructured":"Holanda VAD, Santos WB, Asth L, Guerrini R, Calo\u2019 G, Ruzza C, Gavioli EC (2018) NOP agonists prevent the antidepressant-like effects of nortriptyline and fluoxetine but not R-ketamine. Psychopharmacology (Berl) 235(11):3093\u20133102. https:\/\/doi.org\/10.1007\/s00213-018-5004-7","journal-title":"Psychopharmacology (Berl)"},{"doi-asserted-by":"publisher","unstructured":"Holsboer F (2000) The corticosteroid receptor hypothesis of depression.\u00a0Neuropsychopharmacol 23(5):477\u2013501. https:\/\/doi.org\/10.1016\/S0893-133X(00)00159-7","key":"6533_CR28","DOI":"10.1016\/S0893-133X(00)00159-7"},{"issue":"2","key":"6533_CR29","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/s00213-005-2164-z","volume":"180","author":"EM Jutkiewicz","year":"2005","unstructured":"Jutkiewicz EM, Wood SK, Houshyar H, Hsin LW, Rice KC, Woods JH (2005) The effects of CRF antagonists, antalarmin, CP154,526, LWH234, and R121919, in the forced swim test and on swim-induced increases in adrenocorticotropin in rats. Psychopharmacology (Berl) 180(2):215\u2013223. https:\/\/doi.org\/10.1007\/s00213-005-2164-z","journal-title":"Psychopharmacology (Berl)"},{"issue":"6","key":"6533_CR30","doi-asserted-by":"publisher","first-page":"e1000412","DOI":"10.1371\/journal.pbio.1000412","volume":"8","author":"C Kilkenny","year":"2010","unstructured":"Kilkenny C, Browne WJ, Cuthill IC, Emerson M, Altman DG (2010) Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research. PloS Biol 8(6):e1000412. https:\/\/doi.org\/10.1371\/journal.pbio.1000412","journal-title":"PloS Biol"},{"issue":"11","key":"6533_CR31","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1111\/j.1365-2826.2009.01912.x","volume":"21","author":"JD Leggett","year":"2009","unstructured":"Leggett JD, Dawe KL, Jessop DS, Fulford AJ (2009) Endogenous nociceptin \/ orphanin FQ system involvement in hypothalamic-pituitary-adrenal axis responses: relevance to models of inflammation. J Neuroendocrinol 21(11):888\u2013897. https:\/\/doi.org\/10.1111\/j.1365-2826.2009.01912.x","journal-title":"J Neuroendocrinol"},{"issue":"4","key":"6533_CR32","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.1016\/j.neuroscience.2006.05.036","volume":"141","author":"JD Leggett","year":"2006","unstructured":"Leggett JD, Harbuz MS, Jessop DS, Fulford AJ (2006) The nociceptin receptor antagonist [Nphe1,Arg14,Lys15]nociceptin\/orphanin FQ-NH2 blocks the stimulatory effects of nociceptin\/orphanin FQ on the HPA axis in rats. Neuroscience 141(4):2051\u20132057. https:\/\/doi.org\/10.1016\/j.neuroscience.2006.05.036","journal-title":"Neuroscience"},{"issue":"3","key":"6533_CR33","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/j.neuroscience.2007.04.010","volume":"147","author":"JD Leggett","year":"2007","unstructured":"Leggett JD, Jessop DS, Fulford AJ (2007) The nociceptin\/orphanin FQ antagonist UFP-101 differentially modulates the glucocorticoid response to restraint stress in rats during the peak and nadir phases of the hypothalamo-pituitary-adrenal axis circadian rhythm. Neuroscience 147(3):757\u2013764. https:\/\/doi.org\/10.1016\/j.neuroscience.2007.04.010","journal-title":"Neuroscience"},{"issue":"1","key":"6533_CR34","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/sj.bjp.0705005","volume":"138","author":"M Marti","year":"2003","unstructured":"Marti M, Stocchi S, Paganini F, Mela F, De Risi C, Calo\u2019 G, Guerrini R, Barnes TA, Lambert DG, Beani L, Bianchi C, Morari M (2003) Pharmacological profiles of presynaptic nociceptin\/orphanin FQ receptors modulating 5-hydroxytryptamine and noradrenaline release in the rat neocortex. Br J Pharmacol 138(1):91\u201398. https:\/\/doi.org\/10.1038\/sj.bjp.0705005","journal-title":"Br J Pharmacol"},{"key":"6533_CR35","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.peptides.2015.05.006","volume":"72","author":"IU Medeiros","year":"2015","unstructured":"Medeiros IU, Ruzza C, Asth L, Guerrini R, Rom\u00e3o PR, Gavioli EC, Calo\u2019 G (2015) Blockade of nociceptin\/orphanin FQ receptor signaling reverses LPS-induced depressive-like behavior in mice. Peptides 72:95\u2013103. https:\/\/doi.org\/10.1016\/j.peptides.2015.05.006","journal-title":"Peptides"},{"issue":"5","key":"6533_CR36","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1111\/j.1460-9568.2004.03220.x","volume":"19","author":"F Mela","year":"2004","unstructured":"Mela F, Marti M, Ulazzi L, Vaccari E, Zucchini S, Trapella C, Salvadori S, Beani L, Bianchi C, Morari M (2004) Pharmacological profile of nociceptin\/orphanin FQ receptors regulating 5-hydroxytryptamine release in the mouse neocortex. Eur J Neurosci 19(5):1317\u20131324. https:\/\/doi.org\/10.1111\/j.1460-9568.2004.03220.x","journal-title":"Eur J Neurosci"},{"issue":"2","key":"6533_CR37","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.neuropharm.2009.09.004","volume":"58","author":"C Nazzaro","year":"2010","unstructured":"Nazzaro C, Barbieri M, Varani K, Beani L, Valentino RJ, Siniscalchi A (2010) Swim stress enhances nociceptin\/orphanin FQ-induced inhibition of rat dorsal raphe nucleus activity in vivo and in vitro: role of corticotropin releasing factor. Neuropharmacology 58(2):457\u2013464. https:\/\/doi.org\/10.1016\/j.neuropharm.2009.09.004","journal-title":"Neuropharmacology"},{"issue":"5-6","key":"6533_CR38","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.neuint.2009.01.004","volume":"54","author":"C Nazzaro","year":"2009","unstructured":"Nazzaro C, Marino S, Barbieri M, Siniscalchi A (2009) Inhibition of serotonin outflow by nociceptin\/orphaninFQ in dorsal raphe nucleus slices from normal and stressed rats: role of corticotropin releasing factor. Neurochem Int 54(5-6):378\u2013384. https:\/\/doi.org\/10.1016\/j.neuint.2009.01.004","journal-title":"Neurochem Int"},{"issue":"2","key":"6533_CR39","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/s0306-4522(02)00290-7","volume":"115","author":"JR Nicholson","year":"2002","unstructured":"Nicholson JR, Akil H, Watson SJ (2002) Orphanin FQ-induced hyperphagia is mediated by corticosterone and central glucocorticoid receptors. Neuroscience 115(2):637\u2013643. https:\/\/doi.org\/10.1016\/s0306-4522(02)00290-7","journal-title":"Neuroscience"},{"issue":"5","key":"6533_CR40","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/s0006-3223(00)01088-x","volume":"49","author":"CM Pariante","year":"2001","unstructured":"Pariante CM, Miller AH (2001) Glucocorticoid receptors in major depression: relevance to pathophysiology and treatment. Biol Psychiatry 49(5):391\u2013404. https:\/\/doi.org\/10.1016\/s0006-3223(00)01088-x","journal-title":"Biol Psychiatry"},{"issue":"5604","key":"6533_CR41","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1038\/266730a0","volume":"266","author":"RD Porsolt","year":"1977","unstructured":"Porsolt RD, Le Pichon M, Jalfre M (1977) Depression: a new animal model sensitive to antidepressant treatments. Nature 266(5604):730\u2013732. https:\/\/doi.org\/10.1038\/266730a0","journal-title":"Nature"},{"issue":"7","key":"6533_CR42","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1038\/npp.2015.348","volume":"41","author":"A Post","year":"2016","unstructured":"Post A, Smart TS, Krikke-Workel J, Dawson GR, Harmer CJ, Browning M, Jackson K, Kakar R, Mohs R, Statnick M, Wafford K, McCarthy A, Barth V, Witkin JM (2016) A selective nociceptin receptor antagonist to treat depression: evidence from preclinical and clinical studies. Neuropsychopharmacology 41(7):1803\u20131812. https:\/\/doi.org\/10.1038\/npp.2015.348","journal-title":"Neuropsychopharmacology"},{"key":"6533_CR43","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.bbr.2014.07.052","volume":"277","author":"S Puglisi-Allegra","year":"2015","unstructured":"Puglisi-Allegra S, Andolina D (2015) Serotonin and stress coping. Behav Brain Res 277:58\u201367. https:\/\/doi.org\/10.1016\/j.bbr.2014.07.052","journal-title":"Behav Brain Res"},{"key":"6533_CR44","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.ynstr.2018.01.001","volume":"8","author":"M Randesi","year":"2018","unstructured":"Randesi M, Zhou Y, Mazid S, Odell SC, Gray JD, Correa da Rosa J, McEwen BS, Milner TA, Kreek MJ (2018) Sex differences after chronic stress in the expression of opioid-, stress- and neuroplasticity-related genes in the rat hippocampus. Neurobiol Stress 8:33\u201341. https:\/\/doi.org\/10.1016\/j.ynstr.2018.01.001","journal-title":"Neurobiol Stress"},{"issue":"4","key":"6533_CR45","doi-asserted-by":"publisher","first-page":"e00247","DOI":"10.1002\/prp2.247","volume":"4","author":"A Rizzi","year":"2016","unstructured":"Rizzi A, Cerlesi MC, Ruzza C, Malfacini D, Ferrari F, Bianco S, Costa T, Guerrini R, Trapella C, Calo\u2019 G (2016) Pharmacological characterization of cebranopadol a novel analgesic acting as mixed nociceptin\/orphanin FQ and opioid receptor agonist. Pharmacol Res Perspect 4(4):e00247. https:\/\/doi.org\/10.1002\/prp2.247","journal-title":"Pharmacol Res Perspect"},{"issue":"4","key":"6533_CR46","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/j.neuropharm.2010.12.010","volume":"60","author":"A Rizzi","year":"2011","unstructured":"Rizzi A, Molinari S, Marti M, Marzola G, Calo\u2019 G (2011) Nociceptin\/orphanin FQ receptor knockout rats: in vitro and in vivo studies. Neuropharmacology 60(4):572\u2013579. https:\/\/doi.org\/10.1016\/j.neuropharm.2010.12.010","journal-title":"Neuropharmacology"},{"key":"6533_CR47","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.peptides.2017.07.002","volume":"94","author":"A Rizzi","year":"2017","unstructured":"Rizzi A, Ruzza C, Bianco S, Trapella C, Calo\u2019 G (2017) Antinociceptive action of NOP and opioid receptor agonists in the mouse orofacial formalin test. Peptides 94:71\u201377. https:\/\/doi.org\/10.1016\/j.peptides.2017.07.002","journal-title":"Peptides"},{"issue":"10","key":"6533_CR48","doi-asserted-by":"publisher","first-page":"e12641","DOI":"10.1111\/jne.12641","volume":"30","author":"AL Russell","year":"2018","unstructured":"Russell AL, Tasker JG, Lucion AB, Fiedler J, Munhoz CD, Wu TJ, Deak T (2018) Factors promoting vulnerability to dysregulated stress reactivity and stress-related disease. J Neuroendocrinol 30(10):e12641. https:\/\/doi.org\/10.1111\/jne.12641","journal-title":"J Neuroendocrinol"},{"key":"6533_CR49","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1146\/annurev.clinpsy.1.102803.143948","volume":"1","author":"SM Southwick","year":"2005","unstructured":"Southwick SM, Vythilingam M, Charney DS (2005) The psychobiology of depression and resilience to stress: implications for prevention and treatment. Annu Rev Clin Psychol 1:255\u2013291. https:\/\/doi.org\/10.1146\/annurev.clinpsy.1.102803.143948","journal-title":"Annu Rev Clin Psychol"},{"issue":"11","key":"6533_CR50","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1016\/s0024-3205(01)01217-6","volume":"69","author":"K Takamori","year":"2001","unstructured":"Takamori K, Kawashima N, Chaki S, Nakazato A, Kameo K (2001) Involvement of corticotropin-releasing factor subtype 1 receptor in the acquisition phase of learned helplessness in rats. Life Sci 69(11):1241\u20131248. https:\/\/doi.org\/10.1016\/s0024-3205(01)01217-6","journal-title":"Life Sci"},{"issue":"8","key":"6533_CR51","doi-asserted-by":"publisher","first-page":"3418","DOI":"10.1021\/jm500117r","volume":"57","author":"MA Toledo","year":"2014","unstructured":"Toledo MA, Pedregal C, Lafuente C, Diaz N, Martinez-Grau MA, Jim\u00e9nez A, Benito A, Torrado A, Mateos C, Joshi EM, Kahl SD, Rash KS, Mudra DR, Barth VN, Shaw DB, McKinzie D, Witkin JM, Statnick MA (2014) Discovery of a novel series of orally active nociceptin\/orphanin FQ (NOP) receptor antagonists based on a dihydrospiro(piperidine-4,7\u2032-thieno[2,3-c]pyran) scaffold. J Med Chem 57(8):3418\u20133429. https:\/\/doi.org\/10.1021\/jm500117r","journal-title":"J Med Chem"},{"issue":"23","key":"6533_CR52","doi-asserted-by":"publisher","first-page":"12956","DOI":"10.3390\/ijms222312956","volume":"22","author":"M Ubaldi","year":"2021","unstructured":"Ubaldi M, Cannella N, Borruto AM, Petrella M, Micioni Di Bonaventura MV, Soverchia L, Stopponi S, Weiss F, Cifani C, Ciccocioppo R (2021) Role of nociceptin\/orphanin FQ-NOP receptor system in the regulation of stress-related disorders. Int J Mol Sci 22(23):12956. https:\/\/doi.org\/10.3390\/ijms222312956","journal-title":"Int J Mol Sci"},{"key":"6533_CR53","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.brainres.2009.09.100","volume":"1314","author":"RJ Valentino","year":"2010","unstructured":"Valentino RJ, Lucki I, Van Bockstaele E (2010) Corticotropin-releasing factor in the dorsal raphe nucleus: linking stress coping and addiction. Brain Res 1314:29\u201337. https:\/\/doi.org\/10.1016\/j.brainres.2009.09.100","journal-title":"Brain Res"},{"issue":"8","key":"6533_CR54","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1111\/j.1476-5381.1996.tb15329.x","volume":"117","author":"CW Vaughan","year":"1996","unstructured":"Vaughan CW, Christie MJ (1996) Increase by the ORL1 receptor (opioid receptor-like1) ligand, nociceptin, of inwardly rectifying K conductance in dorsal raphe nucleus neurones. Br J Pharmacol 117(8):1609\u20131611. https:\/\/doi.org\/10.1111\/j.1476-5381.1996.tb15329.x","journal-title":"Br J Pharmacol"},{"issue":"9","key":"6533_CR55","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.1016\/j.peptides.2006.04.003","volume":"27","author":"G Vitale","year":"2006","unstructured":"Vitale G, Arletti R, Ruggieri V, Cifani C, Massi M (2006) Anxiolytic-like effects of nociceptin\/orphanin FQ in the elevated plus maze and in the conditioned defensive burying test in rats. Peptides 27(9):2193\u20132200. https:\/\/doi.org\/10.1016\/j.peptides.2006.04.003","journal-title":"Peptides"},{"issue":"6","key":"6533_CR56","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1177\/0269881117691456","volume":"31","author":"G Vitale","year":"2017","unstructured":"Vitale G, Filaferro M, Micioni Di Bonaventura MV, Ruggieri V, Cifani C, Guerrini R, Simonato M, Zucchini S (2017) Effects of [Nphe1, Arg14, Lys15] N\/OFQ-NH2 (UFP-101), a potent NOP receptor antagonist, on molecular, cellular and behavioural alterations associated with chronic mild stress. J Psychopharmacol 31(6):691\u2013703. https:\/\/doi.org\/10.1177\/0269881117691456","journal-title":"J Psychopharmacol"},{"issue":"2","key":"6533_CR57","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s00213-009-1646-9","volume":"207","author":"G Vitale","year":"2009","unstructured":"Vitale G, Ruggieri V, Filaferro M, Frigeri C, Alboni S, Tascedda F, Brunello N, Guerrini R, Cifani C, Massi M (2009) Chronic treatment with the selective NOP receptor antagonist [Nphe 1, Arg 14, Lys 15]N\/OFQ-NH 2 (UFP-101) reverses the behavioural and biochemical effects of unpredictable chronic mild stress in rats. Psychopharmacology (Berl) 207(2):173\u2013189. https:\/\/doi.org\/10.1007\/s00213-009-1646-9","journal-title":"Psychopharmacology (Berl)"},{"issue":"1","key":"6533_CR58","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.biopsych.2009.02.014","volume":"66","author":"M Waselus","year":"2009","unstructured":"Waselus M, Nazzaro C, Valentino RJ, Van Bockstaele EJ (2009) Stress-induced redistribution of corticotropin-releasing factor receptor subtypes in the dorsal raphe nucleus. Biol Psychiatry 66(1):76\u201383. https:\/\/doi.org\/10.1016\/j.biopsych.2009.02.014","journal-title":"Biol Psychiatry"},{"issue":"16","key":"6533_CR59","doi-asserted-by":"publisher","first-page":"2343","DOI":"10.1016\/s0960-894x(99)00385-6","volume":"9","author":"J Wichmann","year":"1999","unstructured":"Wichmann J, Adam G, R\u00f6ver S, Cesura AM, Dautzenberg FM, Jenck F (1999) 8-Acenaphthen-1-yl-1-phenyl-1,3,8-triaza-spiro[4.5]decan-4-one derivatives as orphanin FQ receptor agonists. Bioorg Med Chem Lett 9(16):2343\u20132348. https:\/\/doi.org\/10.1016\/s0960-894x(99)00385-6","journal-title":"Bioorg Med Chem Lett"},{"issue":"2014","key":"6533_CR60","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.pharmthera.2013.10.011","volume":"141","author":"JM Witkin","year":"2014","unstructured":"Witkin JM, Statnick MA, Rorick-Kehn LM, Pintar JE, Ansonoff M, Chen Y, Tucker RC, Ciccocioppo R (2014) The biology of Nociceptin\/Orphanin FQ (N\/OFQ) related to obesity, stress, anxiety, mood, and drug dependence. Pharmacol Ther 141(2014):283\u2013299. https:\/\/doi.org\/10.1016\/j.pharmthera.2013.10.011","journal-title":"Pharmacol Ther"},{"key":"6533_CR61","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.ynstr.2014.11.002","volume":"1","author":"SK Wood","year":"2015","unstructured":"Wood SK, Bhatnagar S (2015) Resilience to the effects of social stress: evidence from clinical and preclinical studies on the role of coping strategies. Neurobiol Stress 1:164\u2013173. https:\/\/doi.org\/10.1016\/j.ynstr.2014.11.002","journal-title":"Neurobiol Stress"},{"issue":"11","key":"6533_CR62","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1016\/j.biopsych.2013.01.026","volume":"73","author":"SK Wood","year":"2013","unstructured":"Wood SK, Zhang XY, Reyes BA, Lee CS, Van Bockstaele EJ, Valentino RJ (2013) Cellular adaptations of dorsal raphe serotonin neurons associated with the development of active coping in response to social stress. Biol Psychiatry 73(11):1087\u20131094. https:\/\/doi.org\/10.1016\/j.biopsych.2013.01.026","journal-title":"Biol Psychiatry"},{"key":"6533_CR63","doi-asserted-by":"publisher","first-page":"731","DOI":"10.3389\/fpsyt.2018.00731","volume":"9","author":"Y Zhang","year":"2019","unstructured":"Zhang Y, Schalo I, Durand C, Standifer KM (2019) Sex differences in nociceptin\/orphanin FQ peptide receptor-mediated pain and anxiety symptoms in a preclinical model of post-traumatic stress disorder. Front Psychiatry 9:731. https:\/\/doi.org\/10.3389\/fpsyt.2018.00731","journal-title":"Front Psychiatry"},{"issue":"2","key":"6533_CR64","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1111\/bph.12701","volume":"172","author":"Y Zhang","year":"2015","unstructured":"Zhang Y, Simpson-Durand CD, Standifer KM (2015) Nociceptin\/orphanin FQ peptide receptor antagonist JTC-801 reverses pain and anxiety symptoms in a rat model of post-traumatic stress disorder. Br JPharmacol 172(2):571\u2013582. https:\/\/doi.org\/10.1111\/bph.12701","journal-title":"Br JPharmacol"},{"issue":"5","key":"6533_CR65","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1007\/s10571-020-00962-8","volume":"41","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Standifer KM (2021) Exacerbated headache-related pain in the single prolonged stress preclinical model of post-traumatic stress disorder. Cell Mol Neurobiol 41(5):1009\u20131018. https:\/\/doi.org\/10.1007\/s10571-020-00962-8","journal-title":"Cell Mol Neurobiol"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-024-06533-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00213-024-06533-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-024-06533-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,19]],"date-time":"2024-04-19T19:03:24Z","timestamp":1713553404000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00213-024-06533-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,25]]},"references-count":65,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["6533"],"URL":"https:\/\/doi.org\/10.1007\/s00213-024-06533-9","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"type":"print","value":"0033-3158"},{"type":"electronic","value":"1432-2072"}],"subject":[],"published":{"date-parts":[[2024,1,25]]},"assertion":[{"value":"3 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}